Global TAVR Market (Transcatheter Aortic Valve Replacement) Analysis 2013 Edition

The Transcatheter Aortic Valve Replacement (TAVR) is a relatively new technology in medical science which is a less invasive method of replacing the heart valve without undergoing the conventional by-pass surgery. Traditionally, the aortic valve replacement has required open heart surgery, thus disqualifying patients who are at high risk for the process or are too weak to undergo a surgery. Partially for this reason, the market of heart valve surgical procedure is witnessing a continuous decline as more and more patients requiring valve replacement are at high risk for a surgical treatment. This shortcoming of traditional surgery has paved the way for growth of TAVR. It was first commercially launched in Europe in 2007 and later in the United States. The market is very promising and has lot of opportunities and unmet demand to cater to.

Place a direct purchase order of this research report @

Economic growth worldwide, rising income and wealth levels, increasing ageing population and continuously increasing obese population are fueling the development of the global TAVR market. The growth of the TAVR market has high correlation with macro indicators, such as global GDP, and global healthcare expenditure.

This report analyzes the development of the "global TAVR market", with focus on some of the major markets like the United States and Europe. The major trends, drivers facilitating growth of the TAVR market as well as the issues being faced by the industry are being presented in this report. The major players in the TAVR industry including Edward Lifesciences, Medtronic and St. Jude Medical have been profiled in the report highlighting their key financials and strategies for growth.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables affecting this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

Complete report available @

Table of Contents

1. Market Overview

2. TAVR Market Size
Market Value
Procedure Volume
Regional Breakdown
2.1 TAVR Market: Regional Analysis
2.1.1 The US
Market Value
Procedure Volume
Transapical vs. Transfemoral
Price Trend
2.1.2 Europe/ROW
Market Value
Procedure Volume

3. Market Dynamics
3.1 Key Trends
3.1.1 Technological Advancements
3.1.2 Favorable Reimbursement in Europe
3.2 Growth Drivers
3.2.1 Increasing Aging Demographics
3.2.2 Global Economic Development
3.2.3 Increasing Healthcare Expenditure
3.2.4 Increasing Obesity Rates
3.2.5 Increasing Prevalence of Inoperable Aortic Stenosis
3.3 Challenges
3.3.1 Regulatory Issues
3.3.2 Associated High Risk
3.3.3 High Cost of TAVR Devices
3.4 Significant Developments
3.4.1 Corevalve & Corevalve Evolut (TM) Transcatheter Systems by Medtronic
3.4.2 Engager Transcatheter Aortic Valve by Medtronic
3.4.3 Lotus Valve System by Boston Scientific
3.4.4 Portico Transcatheter Aortic Heart Valve by St. Jude Medical

4. Competitive Landscape
Competitive Overview
Market Share
Product Comparison
4.1 The US
4.2 Europe

5. Company Profiles
5.1 Edwards Lifesciences
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
Growth through Research & Development
Offer Innovative Technologies
5.2 Medtronic
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
Focus on Research & Development
Pursue Strategic Acquisitions
5.3 St. Jude Medical
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business strategies
Strategic Acquisitions
Focus on Innovation

6. Market Outlook
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis

List of Tables

TAVR Product Approval Timeline
TAVR Competitive Landscape
Dependent & Independent Variables (2008– 2012)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

List of Charts

Global Transcatheter Aortic Valve Replacement (TAVR) Procedure
Global TAVR Market by Value (20082012)
Global Treatment of Aortic Stenosis (2011 vs. 2020E)
Global Transcatheter Aortic Valve Replacement (TAVR) Procedures (20102013E)
Global Transcatheter Aortic Valve Replacement (TAVR) Market Share, By Region (2012)
The US TAVR Market and Penetration Estimates (20112015E)
The US TAVR Procedures (20112015E)
The US TAVR Procedures  Transapical vs. Transfemoral (20112015E)
TAVR Centers in the US (20112015E)
Average Selling Prices of TAVR in the US (20112015E)
Europe/ROW TAVR Market Size (20102015E)
Aortic Valve Replacements in Europe (2012)
European TAVR Procedures (20102015E)
Growth of Global Aging Population (60 years and above), (20082013E)
World GDP (20052012)
Global Healthcare Expenditure (20082013E)
Global Obese Population (20042012E)
TAVR Market Share by Major Players (2012)
Global TAVR Market Share (20102015E)
The US TAVR Market Share by Major Players (2012)
European TAVR Market Share by Major Players (2012)
Edward’s Lifesciences Net Sales by Product Line (2012)
Edward’s Lifesciences Net Sales by Region (2012)
Edward’s Lifesciences Total Sales & Net Income (20082012)
Global Sales of Edwards Lifesciences TAVR Procedure (20102012)
Medtronic Sales by Product Categories (2012)
Medtronic’s Total Net Revenue and Net Income (20092013)
Global Sales of Medtronic TAVR Procedure (20102012)
St. Jude Medical Sales by Product Categories (2012)
St. Jude Medical’s Net Sales (20082012)
Transcatheter Aortic Valve Replacement Market Forecast (20102016)